
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is well-positioned in the medical device market, with a strong pipeline of new products and a focus on high-growth areas. The company's strategic investments and commitment to sustainability make it an attractive long-term investment. While risks such as competition and policy changes exist, ABT's diversified business model and focus on chronic conditions make it less susceptible to fluctuations in healthcare demand. With a solid performance in Q2 and a raised sales and earnings forecast, ABT is expected to continue its growth trajectory.
Bears say
Abbott Laboratories is rated as a Buy with a $134 price target and a 21x 12-24 month adjusted EPS forecast. With a diversified portfolio and strong presence in high-growth markets such as Medical Devices and Diagnostics, the company has a competitive advantage. Additionally, ABT has made efforts to integrate sustainability into its strategy and has strong financials with projected sales growth of 6.5%-7.5% and adjusted EPS of $5.45-$5.60.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares